Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
A 10 week trial to assess the ability of Tempol to prevent and/or reduce toxicities associated with cisplatin and radiation treatment in head and neck cancer patients. Over the course of the 10 week trial, mucositis, nephrotoxicity, and ototoxicity will be monitored and assessed.
Epistemonikos ID: c38274872049e913bc3981111b30b3752729232d
First added on: May 21, 2024